PT964700E - Preparacao farmaceutica e metodo para o tratamento e prevencao da fibromialgia e da fadiga cronica - Google Patents

Preparacao farmaceutica e metodo para o tratamento e prevencao da fibromialgia e da fadiga cronica

Info

Publication number
PT964700E
PT964700E PT97952162T PT97952162T PT964700E PT 964700 E PT964700 E PT 964700E PT 97952162 T PT97952162 T PT 97952162T PT 97952162 T PT97952162 T PT 97952162T PT 964700 E PT964700 E PT 964700E
Authority
PT
Portugal
Prior art keywords
prevention
treatment
preparation
pharmaceutical preparation
chronic
Prior art date
Application number
PT97952162T
Other languages
English (en)
Inventor
Carl-Gerhard Gottfries
Bjorn Regland
Original Assignee
Gottfriesmottagningen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gottfriesmottagningen Ab filed Critical Gottfriesmottagningen Ab
Publication of PT964700E publication Critical patent/PT964700E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT97952162T 1996-12-30 1997-12-23 Preparacao farmaceutica e metodo para o tratamento e prevencao da fibromialgia e da fadiga cronica PT964700E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604844A SE9604844D0 (sv) 1996-12-30 1996-12-30 Medel för terapeutisk behandling av fibromyalgi och kroniskt trötthetssyndrom

Publications (1)

Publication Number Publication Date
PT964700E true PT964700E (pt) 2004-09-30

Family

ID=20405192

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97952162T PT964700E (pt) 1996-12-30 1997-12-23 Preparacao farmaceutica e metodo para o tratamento e prevencao da fibromialgia e da fadiga cronica

Country Status (10)

Country Link
US (1) US6368590B1 (pt)
EP (1) EP0964700B1 (pt)
AT (1) ATE266419T1 (pt)
AU (1) AU5582198A (pt)
DE (1) DE69729120T2 (pt)
DK (1) DK0964700T3 (pt)
ES (1) ES2221077T3 (pt)
PT (1) PT964700E (pt)
SE (1) SE9604844D0 (pt)
WO (1) WO1998029133A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE523136C2 (sv) * 1999-12-21 2004-03-30 Gottfriesmottagningen Ab Användning av stafylokockbakterier i samband med behandling av irritable bowelsyndrome
AU2009316226B2 (en) * 2008-11-13 2015-08-13 Phillip Comans Agents and treatment for snoring and respiratory effort related arousals in sleep
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP387A (en) * 1991-09-13 1995-07-31 Siegbert Heinrich Bissbort Therapeutical uses of L-methionine and compositions thereof.
AUPM864894A0 (en) * 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
AUPN115095A0 (en) 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease

Also Published As

Publication number Publication date
ES2221077T3 (es) 2004-12-16
WO1998029133A1 (en) 1998-07-09
ATE266419T1 (de) 2004-05-15
EP0964700B1 (en) 2004-05-12
US6368590B1 (en) 2002-04-09
AU5582198A (en) 1998-07-31
SE9604844D0 (sv) 1996-12-30
DE69729120D1 (de) 2004-06-17
DE69729120T2 (de) 2005-04-28
DK0964700T3 (da) 2004-09-06
EP0964700A1 (en) 1999-12-22

Similar Documents

Publication Publication Date Title
McCleane The analgesic efficacy of topical capsaicin is enhanced by glyceryl trinitrate in painful osteoarthritis: a randomized, double blind, placebo controlled study
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
NO20053105D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
NO20014842L (no) Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft
EP0740650A4 (en) CO-MEDICINAL PRODUCTS USED AS A REGULATED MEDICINE DELIVERY PROCESS
SE9301057D0 (sv) Controlled release prepration
Jaswal et al. Comparative evaluation of single application of 2% whole turmeric gel versus 1% chlorhexidine gel in chronic periodontitis patients: A pilot study
WO2002058684A3 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
DE69735848D1 (de) Dosisform mit ansteigender dosisfreisetzung
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
ES2090317T3 (es) Uso del acido 3-guanidinopropionico en la fabricacion de un medicamento para el tratamiento y prevencion del exceso de adiposidad.
UA32457C2 (uk) Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм
DK0624374T3 (da) Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
AR008886A1 (es) Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
PT964700E (pt) Preparacao farmaceutica e metodo para o tratamento e prevencao da fibromialgia e da fadiga cronica
Aubia et al. Dialysis pruritus: effect of cimetidine
EP1197227A4 (en) METHOD FOR ADMINISTERING MEDICINAL PRODUCTS WITH BINDING AFFINITY TO PLASMA PROTEIN AND USE OF THE COMPOSITION IN THE METHOD
FI962985A0 (fi) Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi
Giri et al. Anti-nicotine vaccine: Current status
Caldwell Short-term quazepam treatment of insomnia in geriatric patients
McAfee et al. Effect of the first federally funded US antismoking national media campaign
MXPA04009396A (es) Combinacion que comprende un inhibidor cdk y doxorubicina.